Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Sympatholytics MeSH Descriptor Data 2026


MeSH Heading
Sympatholytics
Tree Number(s)
D27.505.696.663.050.850
Unique ID
D013565
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D013565
Annotation
note entry term SYMPATHOLYTIC EFFECT: use only for the sympatholytic effect of a chemical substance
Scope Note
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
Entry Term(s)
Sympathetic-Blocking Agents
Sympatholytic
Sympatholytic Agent
Sympatholytic Agents
Sympatholytic Drug
Sympatholytic Drugs
Sympatholytic Effect
Sympatholytic Effects
Registry Numbers
0
NLM Classification #
QV 132
See Also
Adrenergic Agents
Adrenergic Antagonists
Public MeSH Note
ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Online Note
use SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81
History Note
ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Date Introduced
1960/01/01
Last Updated
2021/06/30
Sympatholytics Preferred
Sympatholytic Effect Related
page delivered in 0.145s